“Corporate Social Responsibility at Wockhardt is driven by a deep rooted philosophy of sharing and caring. We research and identify areas of need, analyse and optimise our knowledge and resources, and initiate and implement activities designed to bring relief and succour to underprivileged communities around us.
Spearheaded by Wockhardt Foundation, an ISO 9001:2008 certified organization, in collaboration with various corporate partners including Wockhardt Hospitals, our social initiatives include mobile medical service to remote rural locations; facilitating surgeries for children with congenital heart defects; toy libraries for children; e-learing infrastructure in schools; drinking water purification tablets; sanitation facilities in schools and bio-toilets in villages; and skill development.
Last year, we adopted Abdimandi, a village near Aurangabad, under Adarsh Gram Yujna and initiated a comprehensive development programme on multiple levels. We are making steady progress in this unique social model where our goal is to improve and enhance the quality of life through social and community development activities in the area of health, education, sanitation and portable water. During FY 2015-16, the Adarsh Gram Yojna programme was expanded to more village in Aurangabad.”
– Dr. Huzaifa Khorakiwala, Executive Director, Wockhardt; Trustee & CEO, Wockhardt Foundation
Today, Wockhardt has the unique distinction of being the only pharmaceutical company in the world to have 5 of its new drugs under development accorded the coveted Qualified Infectious Disease Product (QIDP) status from US FDA.
Sourced From: Wockhardt Annual Report 2015-16, Photo: drhuz.wordpress.com
